{"id":"W2622171693","doi":"10.1002/hon.2438_45","title":"END OF TREATMENT <scp>PET‐CT</scp> PREDICTS PROGRESSION‐FREE SURVIVAL IN <scp>DLBCL</scp> AFTER FIRST‐LINE TREATMENT: RESULTS FROM THE PHASE III <scp>GOYA</scp> STUDY","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency; University of Alberta","funders":"","keywords":"Medicine; Nuclear medicine; Internal medicine; Clinical endpoint; Rituximab; PET-CT; Diffuse large B-cell lymphoma; Progression-free survival; CHOP; Phases of clinical research; Oncology; Clinical trial; Positron emission tomography; Lymphoma; Overall survival","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00144069,0.0004475918,0.0008092356,0.0001850806,0.0002500258,0.0007617308,0.0004030406,0.0005091528,0.001919243],"category_scores_gemma":[0.0009166744,0.0001996339,0.0009068807,0.0002888093,0.0003768182,0.0003633912,0.0003865329,0.000944278,0.0003203316],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005898238,"about_ca_system_score_gemma":0.0007703926,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008519576,"about_ca_topic_score_gemma":0.001913671,"domain_scores_codex":[0.9996521,0.0001881161,0.0000209425,0.00005511301,0.00004200053,0.00004171826],"domain_scores_gemma":[0.9991547,0.000183026,0.0002672757,0.00006483171,0.00005058825,0.000279584],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5335271,0.006371063,0.3808132,0.0006402443,0.002796944,0.000223246,0.0001496226,0.00185011,0.01238455,0.00009721648,0.002563843,0.05858289],"study_design_scores_gemma":[0.1001659,0.109012,0.7750726,0.0001587695,0.003258728,0.0007604848,0.0001311383,0.00333321,0.003781578,0.0004185393,0.003865004,0.00004190324],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976684,0.0008720456,0.0001162749,0.0001067515,0.0000152629,0.0001957621,0.0006176346,0.000008055893,0.0003997819],"genre_scores_gemma":[0.9974822,0.0003571637,0.0001770356,0.0001189385,0.00003295086,0.0002045291,0.001373867,0.000004165488,0.0002490844],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001919243,"threshold_uncertainty_score":0.007619202,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05398042620619866,"score_gpt":0.3550490730967307,"score_spread":0.3010686468905321,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}